(Q39262600)

10 September 2017

A tumor hypoxic niche protects human colon cancer stem cells from chemotherapy (English)

1 reference

10 September 2017

0 references

1 reference

neoplastic stem cells

1 reference

1 reference

Qin Mao

1

1 reference

10 September 2017

Yu Zhang

2

1 reference

10 September 2017

Xiaoyue Fu

3

1 reference

10 September 2017

Jianxin Xue

4

1 reference

10 September 2017

Wenhao Guo

5

1 reference

10 September 2017

Maobing Meng

6

1 reference

10 September 2017

Zongguang Zhou

7

1 reference

10 September 2017

Xianming Mo

8

1 reference

10 September 2017

You Lu

9

1 reference

10 September 2017

30 September 2012

1 reference

Journal of Cancer Research and Clinical Oncology

10 September 2017

1 reference

10 September 2017

139

1 reference

10 September 2017

211-222

1 reference

10 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-012-1310-3

10 September 2017

0 references

cites work

Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Tumor hypoxia in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

A perivascular niche for brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Breast cancer, stem/progenitor cells and the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Regulation of human placental development by oxygen tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Hypoxia requires notch signaling to maintain the undifferentiated cell state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Primary Bioassay of Human Tumor Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Cancer stem cells in solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

CD133 expression is an independent prognostic marker for low survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Hypoxia-inducible factors, stem cells, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Hematopoietic progenitor cell mobilization results in hypoxia with increased hypoxia-inducible transcription factor-1 alpha and vascular endothelial growth factor A in bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Systemic therapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Stem cells and their niches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Advances in chemotherapy against advanced or metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Applying the principles of stem-cell biology to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Influence of oxygen tension on CD133 phenotype in human glioma cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Hypoxia signalling in cancer and approaches to enforce tumour regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

The stem cell niches in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1310-3

Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers

21 January 2018

1 reference

12 December 2020

The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

1 reference

12 December 2020

CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors

1 reference

12 December 2020

Is CD133 a marker of metastatic colon cancer stem cells?

1 reference

12 December 2020

Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer

1 reference

12 December 2020

Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene.

1 reference

12 December 2020

10.1007/S00432-012-1310-3

Identifiers

DOI

1 reference

10 September 2017

1 reference